tag:blogger.com,1999:blog-18943510.post4440398392779150980..comments2023-08-21T02:57:37.362-05:00Comments on Dr. Wes: The Government's Research Double-StandardDrWeshttp://www.blogger.com/profile/17438019699222125477noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-18943510.post-337383311336818042011-06-07T08:25:43.892-05:002011-06-07T08:25:43.892-05:00When I see a patient with a left cheek mass, I don...When I see a patient with a left cheek mass, I don't use a "consensus" to decide what to do. I use judgment, based on my training and experience to choose to do an FNA on this mass before moving on to more expensive, invasive, and costly methods. If a new way comes along to investigate this problem, I likely have enough judgment to make an initial decision about whether it is Timnoreply@blogger.comtag:blogger.com,1999:blog-18943510.post-76303343365077939592011-06-06T17:47:36.036-05:002011-06-06T17:47:36.036-05:00Wes,
You may be talking apples and oranges here. ...Wes,<br /><br />You may be talking apples and oranges here. <br /><br />What the drug companies are restricted to marketing is what is clearly proven by studies to be the benefit of the drug and what it is FDA approved for. They need to reach FDA criteria of adequate study to promote their product for indications other than the FDA approved reason for use.<br /><br />Clinical guidelines depend Keithnoreply@blogger.com